182 related articles for article (PubMed ID: 30928936)
1. The impact of decentralising colposcopy services from tertiary-level to primary-level care in inner-city Johannesburg, South Africa: a before and after study.
Maimela G; Nene X; Mvundla N; Sawry S; Smith T; Rees H; Kachingwe E; Chersich M
BMJ Open; 2019 Mar; 9(3):e024726. PubMed ID: 30928936
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
3. [Following-up females having an abnormal Pap smear in Colombia].
Wiesner C; Cendales R; Murillo R; Piñeros M; Tovar S
Rev Salud Publica (Bogota); 2010 Feb; 12(1):1-13. PubMed ID: 20628695
[TBL] [Abstract][Full Text] [Related]
4. Minimally abnormal Pap testing and cervical histology in HIV-infected women.
Curry CL; Sage YH; Vragovic O; Stier EA
J Womens Health (Larchmt); 2012 Jan; 21(1):87-91. PubMed ID: 22011239
[TBL] [Abstract][Full Text] [Related]
5. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
6. Design and methods of the evaluation of an HPV-based cervical cancer screening strategy in Mexico: The Morelos HPV Study.
Flores Y; Shah K; Lazcano E; Hernández M; Bishai D; Ferris DG; Lörincz A; Hernández P; Salmerón J;
Salud Publica Mex; 2002; 44(4):335-44. PubMed ID: 12216521
[TBL] [Abstract][Full Text] [Related]
7. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of abnormal cervical cytology by liquid based cytology in the antenatal care clinic, Thammasat University Hospital.
Khaengkhor P; Mairaing K; Suwannarurk K; Thaweekul Y; Poomtavorn Y; Pattaraarchachai J; Bhamarapravatana K
J Med Assoc Thai; 2011 Feb; 94(2):152-8. PubMed ID: 21534360
[TBL] [Abstract][Full Text] [Related]
9. Women's experiences with cervical cancer screening in a colposcopy referral clinic in Cape Town, South Africa: a qualitative analysis.
Momberg M; Botha MH; Van der Merwe FH; Moodley J
BMJ Open; 2017 Feb; 7(2):e013914. PubMed ID: 28213603
[TBL] [Abstract][Full Text] [Related]
10. Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years.
Luyten A; Scherbring S; Reinecke-Lüthge A; Braun BE; Pietralla M; Theiler K; Petry KU
J Clin Virol; 2009 Nov; 46 Suppl 3():S5-10. PubMed ID: 20129072
[TBL] [Abstract][Full Text] [Related]
11. Mapping the cervical cancer screening cascade among women living with HIV in Johannesburg, South Africa
Rohner E; Mulongo M; Pasipamire T; Oberlin AM; Goeieman B; Williams S; Lubeya MK; Rahangdale L; Chibwesha CJ
Int J Gynaecol Obstet; 2021 Jan; 152(1):53-59. PubMed ID: 33188707
[TBL] [Abstract][Full Text] [Related]
12. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance, after six months delay: a three-year experience in an Iranian university hospital.
Yarandi F; Shojaei H; Eftekhar Z; Izadi-Mood N
Aust N Z J Obstet Gynaecol; 2009 Apr; 49(2):207-10. PubMed ID: 19432613
[TBL] [Abstract][Full Text] [Related]
13. Utilisation and outcomes of cervical cancer prevention services among HIV-infected women in Cape Town.
Batra P; Kuhn L; Denny L
S Afr Med J; 2010 Jan; 100(1):39-44. PubMed ID: 20429487
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal assessment of abnormal Papanicolaou test rates among women with HIV.
Massad LS; Xie X; Minkoff H; Kassaye S; Karim R; Darragh TM; Golub ET; Adimora A; Wingood G; Fischl M; Konkle-Parker D; Strickler HD
AIDS; 2020 Jan; 34(1):73-80. PubMed ID: 31789890
[TBL] [Abstract][Full Text] [Related]
15. Human papilloma virus testing knowledge and attitudes among women attending colposcopy clinic with ASCUS/LGSIL pap smears.
Le T; Hicks W; Menard C; Boyd D; Hewson T; Hopkins L; Kee Fung MF
J Obstet Gynaecol Can; 2004 Sep; 26(9):788-92. PubMed ID: 15361273
[TBL] [Abstract][Full Text] [Related]
16. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
17. Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear.
Monsonego J; Pollini G; Evrard MJ; Sednaoui P; Monfort L; Quinzat D; Dachez R; Syrjänen K
Int J STD AIDS; 2008 Jun; 19(6):385-92. PubMed ID: 18595876
[TBL] [Abstract][Full Text] [Related]
18. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.
Wentzensen N; Walker J; Smith K; Gold MA; Zuna R; Massad LS; Liu A; Silver MI; Dunn ST; Schiffman M
Am J Obstet Gynecol; 2018 Jun; 218(6):604.e1-604.e8. PubMed ID: 29462629
[TBL] [Abstract][Full Text] [Related]
20. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa.
Adam Y; McIntyre JA; De Bruyn G
S Afr Med J; 2012 Nov; 103(1):34-9. PubMed ID: 23237122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
